American Herbal Products Association (AHPA) > News > Press Room

Press Room

Our Mission

The American Herbal Products Association (AHPA) is the national trade association and voice of the herbal products industry. Founded in 1982, AHPA's mission is to promote the responsible commerce of herbal products to ensure that consumers continue to enjoy informed access to a wide variety of herbal goods.

Our Expertise

AHPA has particular expertise on the history, science, and regulation of botanicals while its work also has significant influence on non-herbal dietary supplements. Similarly, AHPA expends its resources on issues in the U.S. marketplace and in the international arena, wherever member interests are served.

Our Members

AHPA is comprised of more than 350 domestic and international companies conducting business as growers, processors, manufacturers, and marketers of herbs and herbal products. AHPA members’ herbal products are in tea, beverage, dietary supplement, sports nutrition, personal care, pet and other product categories. AHPA membership also includes individuals, companies and organizations who serve the industry, including consultants, attorneys, media, researchers, educators, and medical professionals.

Learn more about AHPA >>

AHPA Press Releases and Updates for the Media

[Cannabis Alert] Senators announce new federal policy on cannabidiol research (Feinstein Press Release)

Editor's Note: Sens. Dianne Feinstein (D-CA) and Chuck Grassley (R-IA) announced that the Department of Justice (DOJ) will conduct its first "eight-factor analysis" of cannabidiol to determine the substance's potential medical benefit. The senators also highlighted the Department of Health and Human Services (HHS) announcement that it will no longer require privately-funded researchers to submit their research proposals for an additional review by the Public Health Service, a requirement that did not apply to any other Schedule I substance. The Senators issued the announcement in conjunction with a hearing, "Cannabidiol: Barriers to Research and Potential Medical Benefits," held this morning by the Senate Caucus on International Narcotics Control and attended by AHPA's Federal lobbyist, Pete Evich. 

[Cosmetics Alert] Terpenoids effective for treatment of some dermatologic diseases (J Alt Comp Med)

Editor's Note: This review of 13 clinical trials of dermatology-specific terpenoid-based treatments concludes that these phytochemicals appear to be effective in treating specific dermatologic conditions such as actinic keratosis, nonmelanoma skin cancers, cutaneous candidiasis, hyperpigmentation, photoaging, and wounds. The terpenoids discussed are ingenol mebutate from Euphorbia peplus, menthol from Mentha piperita, α-bisabolol of Matricaria chamomilla, boswellic acid from Boswellia serrata, asiaticoside from Centella asiatica, and betulin of the Betula species.

AHPA submits comments on proposed amendments to registration of food facilities

AHPA on Monday submitted comments on the FDA's proposed rule for the registration of food facilities, which amends and updates current registration regulations as part of the implementation of the Food Safety Modernization Act (FSMA)

AHPA comments on California proposal to list goldenseal, aloe as 'known to cause cancer' under Prop 65

AHPA criticizes one of the mechanisms OEHHA uses to add substances to the Prop 65 list

AHPA submitted comments in response to OEHHA's Notice of Intent to List goldenseal root powder and Aloe vera, whole leaf extract, as known to the state to cause cancer under Proposition 65

[Cosmetics Alert] Warning letters highlight differences between cosmetics and medical devices (FDA)

Editor's Note: In this FDA notice, the agency highlights recent warning letters to stress the difference between medical devices and cosmetics. The devices cited in the warning letters are intended to affect a person's appearance which is part of the definition of a cosmetic product, however the fact that they are intended to diagnose or treat a medical condition or affect the structure or function of the body makes them medical devices. As such, the Federal Food, Drug, & Cosmetic (FD&C) Act requires medical device manufacturers to obtain from FDA approval and marketing clearance for products before offering them for sale. Premarket approval per se is not required for cosmetic products or ingredients.

AHPA Revises Guidance on Prop 65 Warnings for Pulegone

Does Naturally Occurring Pulegone Represent 'Exposure' Under CA Prop 65?

AHPA has updated guidance to help members understand and comply with California Proposition 65 requirements when selling products that contain pulegone, a ketonic monoterpene that is a naturally present constituent in various plant species, including mints.

Limitations of DNA testing for botanical identification

DNA analysis can generate false negative results due to the normal and expected lack of DNA in some processed herbal ingredients

The statement provides the view of the American Herbal Products Association of the current state of the science of the use of DNA barcoding as a technique for authenticating the identity of herbal materials for this purpose and is intended to explain any misunderstandings that may arise out of the March 30 agreement as to the currently limited applicability of this analytical technique.

AHPA Adopts Policy Against Sale of Bulk Caffeine

Recent reports associate serious injury and death with use of pure caffeine purchased by consumers in bulk packaging.

The American Herbal Products Association (AHPA) Board of Trustees on March 4 established a trade requirement that prohibits sale by AHPA members of pure caffeine in bulk form at retail (to consumers).

Whitepaper on DNA barcode testing reveals how misapplication of science led to baseless results

The Capabilities and Limitations of DNA Barcode Testing

A comprehensive analysis of DNA barcode testing on botanical dietary supplements has called conclusions reached by the New York Attorney General’s (NY AG) office in an investigation of four major retailers of botanical supplements, a “…misuse of the technologies” that led to a “…misinterpretation of test results.”

AHPA responds to dozens of media outlets' coverage of New York Attorney General's inadequate testing of herbal supplements

AHPA has responded to more than 20 media outlets' coverage of the New York State Attorney General's supplement investigation to stress that the allegations are based on inadequate and unproven testing of herbal supplement products. The test results are at the core of the Attorney General's misinformed allegations that several major retailers are selling adulterated and/or mislabeled herbal dietary supplements. 
First 234567891011

2017 Annual Fund Sponsors


AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.